title: How do vaccinia-vectored vaccines fit into animal immunization programmes?
authors.affiliation: Department of Virology, Wellcome Biotech, Beckenham, Kent (UK).
authors.forename: F
authors.initials: F
authors.lastname: Brown
mesh_terms: D000818:Animals; D006691:Classical Swine Fever / Q000517:prevention & control; D005536:Foot-and-Mouth Disease / Q000517:prevention & control; D005822:Genetic Vectors; D007114:Immunization / Q000662:veterinary*; D011818:Rabies / Q000517:prevention & control / Q000662:veterinary; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000517:prevention & control / Q000662:veterinary; D012295:Rift Valley Fever / Q000517:prevention & control; D012301:Rinderpest / Q000517:prevention & control; D013552:Swine; D014612:Vaccines; D014614:Vaccines, Synthetic; D014616:Vaccinia virus; D014765:Viral Vaccines
chemical_list: D014612:Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines